Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Marcus Westerberg, Ingela Franck Lissbrant, Jan Erik Damber, David Robinson, Hans Garmo & Pär Stattin. (2020) Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study. Acta Oncologica 59:1, pages 106-111.
Read now
Read now
Nina Klemann, Martin Andreas Røder, John Thomas Helgstrand, Klaus Brasso, Birgitte G. Toft, Ben Vainer & Peter Iversen. (2018) The use of transrectal ultrasound-guided biopsy following the introduction of prostate-specific antigen testing in Denmark: a population-based analysis. Scandinavian Journal of Urology 52:3, pages 169-173.
Read now
Read now
Thore Hillig, Torben Kjær Nielsen, Steen Ingemann Hansen, Ann-Britt Nygaard & György Sölétormos. (2017) Elevated prostate specific antigen and reduced 10-year survival among a cohort of Danish men consecutively referred from primary care to an urological department during 2005–2006. Scandinavian Journal of Clinical and Laboratory Investigation 77:1, pages 27-35.
Read now
Read now
Frederik B. Thomsen, Marta K. Mikkelsen, Rikke B. Hansen, Andrea H. Krug, Anders Glenthøj, Pär Stattin & Klaus Brasso. (2016) Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center. Acta Oncologica 55:12, pages 1456-1460.
Read now
Read now
Julia R Murray, Helen A McNair & David P Dearnaley. (2015) Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?. Cancer Management and Research 7, pages 331-344.
Read now
Read now
Articles from other publishers (19)
Magdalena Lycken, Oskar Bergengren, Linda Drevin, Hans Garmo, Marcus Westerberg, Elin Axén, Johan Stranne, Lars Holmberg & Anna Bill-Axelson. (2022) Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths. European Urology Open Science 41, pages 81-87.
Crossref
Crossref
Sean A. Fletcher, Nicolas von Landenberg, Alexander P. Cole, Philipp Gild, Toni K. Choueiri, Stuart R. Lipsitz, Quoc-Dien Trinh & Adam S. Kibel. (2019) Contemporary national trends in prostate cancer risk profile at diagnosis. Prostate Cancer and Prostatic Diseases 23:1, pages 81-87.
Crossref
Crossref
Kerri Beckmann, Netty Kinsella, Henrik Olsson, Anna Wallerstedt Lantz, Tobias Nordstrom, Markus Aly, Jan Adolfsson, Martin Eklund & Mieke Van Hemelrijck. (2019) Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?. BMC Urology 19:1.
Crossref
Crossref
Sophie Knipper, David Pröwrock, Zhe Tian, Hans Heinzer, Derya Tilki, Pierre Karakiewicz & Markus Graefen. (2019) External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomy. World Journal of Urology 37:12, pages 2649-2655.
Crossref
Crossref
S. Roy & S.C. Morgan. (2019) Who Dies From Prostate Cancer? An Analysis of the Surveillance, Epidemiology and End Results Database. Clinical Oncology 31:9, pages 630-636.
Crossref
Crossref
Walter Cazzaniga, Hans Garmo, David Robinson, Lars Holmberg, Anna Bill-Axelson & Pär Stattin. (2019) Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study. BJU International 123:3, pages 421-428.
Crossref
Crossref
Gitte Kristensen, Martin Andreas Røder, Kasper Drimer Berg, Johanna Elversang, Diego Iglesias-Gato, José Moreira, Birgitte Grønkaer Toft & Klaus Brasso. (2018) Predictive value of combined analysis of pro-NPY and ERG in localized prostate cancer. APMIS 126:10, pages 804-813.
Crossref
Crossref
Marco Bandini, Elio Mazzone, Felix Preisser, Sebastiano Nazzani, Emanuele Zaffuto, Michele Marchioni, Zhe Tian, Raisa S. Pompe, Derya Tilki, Markus Graefen, Shahrokh F. Shariat, Francesco Montorsi, Fred Saad, Alberto Briganti & Pierre Karakiewicz. (2018) Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database. European Urology Oncology 1:4, pages 314-320.
Crossref
Crossref
John T. Helgstrand, Martin A. Røder, Nina Klemann, Birgitte G. Toft, Daphne Y. Lichtensztajn, James D. Brooks, Klaus Brasso, Ben Vainer & Peter Iversen. (2018) Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts. Cancer 124:14, pages 2931-2938.
Crossref
Crossref
Jeffrey J. Tosoian, Mufaddal Mamawala, Hiten D. Patel, Ridwan Alam, Jonathan I. Epstein, Ashley E. Ross & H. Ballentine Carter. (2018) Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance. The Journal of Urology 199:4, pages 954-960.
Crossref
Crossref
Sami-Ramzi Leyh-Bannurah, Stéphanie Gazdovich, Lars Budäus, Emanuele Zaffuto, Paolo Dell'Oglio, Alberto Briganti, Firas Abdollah, Francesco Montorsi, Jonas Schiffmann, Mani Menon, Shahrokh F. Shariat, Margit Fisch, Felix Chun, Markus Graefen & Pierre I. Karakiewicz. (2017) Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients. The Prostate 77:1, pages 105-113.
Crossref
Crossref
Jeffrey J. Tosoian & H. Ballentine Carter. (2016) Active Surveillance of Localized Prostate Cancer: Acknowledging Uncertainty. Journal of Clinical Oncology 34:36, pages 4452-4452.
Crossref
Crossref
Frederik B. Thomsen, Yasin Folkvaljon, Klaus Brasso, Stacy Loeb, David Robinson, Lars Egevad & Pär Stattin. (2016) Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy. Journal of Surgical Oncology 114:6, pages 664-670.
Crossref
Crossref
Rami Klaff, Anders Berglund, Eberhard Varenhorst, Per Olov Hedlund, Morten Jǿnler & Gabriel Sandblom. (2016) Clinical characteristics and quality-of-life in patients surviving a decade of prostate cancer with bone metastases. BJU International 117:6, pages 904-913.
Crossref
Crossref
Nicola Fossati, Niccolò M. Passoni, Marco Moschini, Giorgio Gandaglia, Alessandro Larcher, Massimo Freschi, Giorgio Guazzoni, Daniel D. Sjoberg, Andrew J. Vickers, Francesco Montorsi & Alberto Briganti. (2016) Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades. BJU International 117:5, pages 740-747.
Crossref
Crossref
Rami Klaff, Johan Rosell, Eberhard Varenhorst & Gabriel Sandblom. (2016) The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades. Urology 91, pages 77-82.
Crossref
Crossref
Roderick C.N. van den Bergh, Stacy Loeb & Monique J. Roobol. (2015) Impact of Early Diagnosis of Prostate Cancer on Survival Outcomes. European Urology Focus 1:2, pages 137-146.
Crossref
Crossref
Roderick C.N. van den Bergh, Declan G. Murphy & Anthony J. Costello. (2015) Identification of candidates for observation. Current Opinion in Urology 25:3, pages 252-257.
Crossref
Crossref
Robertas Adomaitis, Mindaugas Jievaltas, Albertas Ulys, Giedrė Smailytė, Vytautas Kasiulevičius & Feliksas Jankevičius. (2015) Lietuvos priešinės liaukos vėžio ankstyvosios diagnostikos programos patikros eiga 1942–1956 m. gimusių vyrų grupėje. Medicinos teorija ir praktika 21:2.2, pages 267-270.
Crossref
Crossref